At Clarient, we combine innovative diagnostic technologies with world-class pathology expertise to assess and characterize cancer. Our mission is to become the leader in cancer diagnostics by dedicating ourselves to collaborative relationships with the healthcare community to translate cancer discovery and research into better patient care. Our principal customers include pathologists, oncologists, hospitals and biopharmaceutical companies.
The rise of individualized medicine as the new direction in oncology has created the need for a centralized resource providing leading diagnostic technologies, such as flow cytometry and molecular testing. Clarient is that resource, with a state-of-the-art commercial cancer laboratory providing the most advanced oncology testing and diagnostic services. We are also developing new, proprietary “companion” diagnostic markers for therapeutics in breast, prostate, lung and colon cancers, and leukemia/lymphoma.